Presumably, the exhausted Flt3m-CAR T-cells and Flt3-CAR T-cells can interact with tumor cells through the Flt3-ligand:Flt3 receptor interface, blocking access to active Flt3m-CAR T-cells and Flt3-CAR T-cells. The gene discussed is FLT3; the disease is neoplasm.